User experience of applying AMSTAR 2 to appraise systematic reviews of healthcare interventions: a commentary

Abstract Background ‘A Measurement Tool to Assess Systematic Reviews, version 2’ (AMSTAR 2) is a validated 16-item scale designed to appraise systematic reviews (SRs) of healthcare interventions and to rate the overall confidence in their results. This commentary aims to describe the challenges with...

Full description

Bibliographic Details
Main Authors: Karina Karolina De Santis, Dawid Pieper, Robert C. Lorenz, Uta Wegewitz, Waldemar Siemens, Katja Matthias
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Medical Research Methodology
Subjects:
Online Access:https://doi.org/10.1186/s12874-023-01879-8
_version_ 1797864330228662272
author Karina Karolina De Santis
Dawid Pieper
Robert C. Lorenz
Uta Wegewitz
Waldemar Siemens
Katja Matthias
author_facet Karina Karolina De Santis
Dawid Pieper
Robert C. Lorenz
Uta Wegewitz
Waldemar Siemens
Katja Matthias
author_sort Karina Karolina De Santis
collection DOAJ
description Abstract Background ‘A Measurement Tool to Assess Systematic Reviews, version 2’ (AMSTAR 2) is a validated 16-item scale designed to appraise systematic reviews (SRs) of healthcare interventions and to rate the overall confidence in their results. This commentary aims to describe the challenges with rating of the individual items and the application of AMSTAR 2 from the user perspective. Discussion A group of six experienced users (methodologists working in different clinical fields for at least 10 years) identified and discussed the challenges in rating of each item and the general use of AMSTAR 2 to appraise SRs. A group discussion was used to develop recommendations on how users could deal with the identified challenges. We identified various challenges with the content of items 2–16 and with the derivation of the overall confidence ratings on AMSTAR 2. These challenges include the need (1) to provide additional definitions (e.g., what constitutes major deviations from SR protocol on item 2), (2) to choose a rating strategy for multiple conditions on single items (e.g., how to rate item 5 if studies were selected in duplicate, but consensus between two authors was not reported), and (3) to determine rules for deriving the confidence ratings (e.g., what items are critical for such ratings). Based on these challenges we formulated specific recommendations for items 2–16 that AMSTAR 2 users could consider before applying the tool. Summary Our commentary adds to the existing literature by providing the first in-depth examination of the AMSTAR 2 tool from the user perspective. The identified challenges could be addressed by additional decision rules including definitions for ambiguous items and guidance for rating of complex items and derivation of confidence ratings. We recommend that a team consensus regarding such decision rules is required before appraisal procedure begins. Trial registration Not applicable.
first_indexed 2024-04-09T22:50:04Z
format Article
id doaj.art-10849d7501d548c68d066f0e81f6aab4
institution Directory Open Access Journal
issn 1471-2288
language English
last_indexed 2024-04-09T22:50:04Z
publishDate 2023-03-01
publisher BMC
record_format Article
series BMC Medical Research Methodology
spelling doaj.art-10849d7501d548c68d066f0e81f6aab42023-03-22T11:38:56ZengBMCBMC Medical Research Methodology1471-22882023-03-0123111010.1186/s12874-023-01879-8User experience of applying AMSTAR 2 to appraise systematic reviews of healthcare interventions: a commentaryKarina Karolina De Santis0Dawid Pieper1Robert C. Lorenz2Uta Wegewitz3Waldemar Siemens4Katja Matthias5Department of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology – BIPS GmbHBrandenburg Medical School Theodor Fontane (MHB), Center for Health Services Research (ZVF-BB)Lise Meitner Group for Environmental Neuroscience, Max Planck Institute for Human DevelopmentFederal Institute for Occupational Safety and Health (BAuA), Division 3 Work and HealthFaculty of Medicine, Institute for Evidence in Medicine, Medical Center - University of Freiburg, University of FreiburgFaculty of Electrical Engineering and Computer Science, University of Applied Sciences StralsundAbstract Background ‘A Measurement Tool to Assess Systematic Reviews, version 2’ (AMSTAR 2) is a validated 16-item scale designed to appraise systematic reviews (SRs) of healthcare interventions and to rate the overall confidence in their results. This commentary aims to describe the challenges with rating of the individual items and the application of AMSTAR 2 from the user perspective. Discussion A group of six experienced users (methodologists working in different clinical fields for at least 10 years) identified and discussed the challenges in rating of each item and the general use of AMSTAR 2 to appraise SRs. A group discussion was used to develop recommendations on how users could deal with the identified challenges. We identified various challenges with the content of items 2–16 and with the derivation of the overall confidence ratings on AMSTAR 2. These challenges include the need (1) to provide additional definitions (e.g., what constitutes major deviations from SR protocol on item 2), (2) to choose a rating strategy for multiple conditions on single items (e.g., how to rate item 5 if studies were selected in duplicate, but consensus between two authors was not reported), and (3) to determine rules for deriving the confidence ratings (e.g., what items are critical for such ratings). Based on these challenges we formulated specific recommendations for items 2–16 that AMSTAR 2 users could consider before applying the tool. Summary Our commentary adds to the existing literature by providing the first in-depth examination of the AMSTAR 2 tool from the user perspective. The identified challenges could be addressed by additional decision rules including definitions for ambiguous items and guidance for rating of complex items and derivation of confidence ratings. We recommend that a team consensus regarding such decision rules is required before appraisal procedure begins. Trial registration Not applicable.https://doi.org/10.1186/s12874-023-01879-8AMSTAR 2Systematic review (SR)Evidence appraisalConfidence rating
spellingShingle Karina Karolina De Santis
Dawid Pieper
Robert C. Lorenz
Uta Wegewitz
Waldemar Siemens
Katja Matthias
User experience of applying AMSTAR 2 to appraise systematic reviews of healthcare interventions: a commentary
BMC Medical Research Methodology
AMSTAR 2
Systematic review (SR)
Evidence appraisal
Confidence rating
title User experience of applying AMSTAR 2 to appraise systematic reviews of healthcare interventions: a commentary
title_full User experience of applying AMSTAR 2 to appraise systematic reviews of healthcare interventions: a commentary
title_fullStr User experience of applying AMSTAR 2 to appraise systematic reviews of healthcare interventions: a commentary
title_full_unstemmed User experience of applying AMSTAR 2 to appraise systematic reviews of healthcare interventions: a commentary
title_short User experience of applying AMSTAR 2 to appraise systematic reviews of healthcare interventions: a commentary
title_sort user experience of applying amstar 2 to appraise systematic reviews of healthcare interventions a commentary
topic AMSTAR 2
Systematic review (SR)
Evidence appraisal
Confidence rating
url https://doi.org/10.1186/s12874-023-01879-8
work_keys_str_mv AT karinakarolinadesantis userexperienceofapplyingamstar2toappraisesystematicreviewsofhealthcareinterventionsacommentary
AT dawidpieper userexperienceofapplyingamstar2toappraisesystematicreviewsofhealthcareinterventionsacommentary
AT robertclorenz userexperienceofapplyingamstar2toappraisesystematicreviewsofhealthcareinterventionsacommentary
AT utawegewitz userexperienceofapplyingamstar2toappraisesystematicreviewsofhealthcareinterventionsacommentary
AT waldemarsiemens userexperienceofapplyingamstar2toappraisesystematicreviewsofhealthcareinterventionsacommentary
AT katjamatthias userexperienceofapplyingamstar2toappraisesystematicreviewsofhealthcareinterventionsacommentary